Post by DREHM Pharma GmbH

Value chains under pressure: Why resilience requires more than just localization. Geopolitical tensions, rising costs, and regulatory requirements are presenting new challenges for the pharmaceutical supply chain. 👉 Our CEO Sandra Hartbach contributed to this year’s CPHI Pharma Trends Outlook Report, highlighting the key areas of tension: While other regions are pushing their strategies forward with greater determination, Europe often lacks a unified approach. 💡 Takeaway: Resilience does not come from complete localization. What is needed is a balanced strategy that specifically strengthens regional capacities while also emphasizing geographically diversified value chains. Only in this way can costs, supply security, and regulatory requirements be sustainably reconciled. 📄 Read more in the full report (link in the first comment) Thank you Vivian X. for including us!   DREHM Pharma. Sharing Experience. 🌐 #drehm #sharingexperience #cphi